Login / Signup

Impact of skeletal muscle volume on patients with BCLC stage-B hepatocellular carcinoma undergoing sorafenib therapy.

Issei SaekiTakahiro YamasakiYurika YamauchiTomokazu KawaokaShinsuke UchikawaAkira HiramatsuHiroshi AikataKazufumi KobayashiTakayuki KondoSadahisa OgasawaraTetsuhiro ChibaReo KawanoKazuaki ChayamaNaoya KatoTaro Takami
Published in: Cancer medicine (2023)
Skeletal muscle volume showed little impact on the clinical outcomes of patients with BCLC-B undergoing sorafenib therapy.
Keyphrases
  • skeletal muscle
  • insulin resistance
  • stem cells
  • type diabetes
  • metabolic syndrome
  • mesenchymal stem cells